Viewing Study NCT00066768


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2025-12-28 @ 10:41 AM
Study NCT ID: NCT00066768
Status: COMPLETED
Last Update Posted: 2013-06-04
First Post: 2003-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module